UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Lose Dose

Digestive diseases and sciences, 2019-06, Vol.64 (6), p.1672-1678

2019

Volltextzugriff (PDF)

Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis

Clinical gastroenterology and hepatology, 2022-01, Vol.20 (1), p.126-135

2022

Volltextzugriff (PDF)

Impact of withdrawal time on adenoma detection rate: results from a prospective multicenter trial

Gastrointestinal endoscopy, 2023-03, Vol.97 (3), p.537-543.e2

2023

Volltextzugriff (PDF)

Diagnosis and Management of Small Intestinal Bacterial Overgrowth

Nutrition in clinical practice, 2013-06, Vol.28 (3), p.289-299

2013

Volltextzugriff (PDF)

Clinical Presentation of Small Intestinal Bacterial Overgrowth from Aerodigestive Tract Bacteria Versus Colonic-Type Bacteria: A Comparison Study

Digestive diseases and sciences, 2023-08, Vol.68 (8), p.3390-3399

2023

Volltextzugriff (PDF)

Delayed Gastric Emptying Is Not Associated with a Microbiological Diagnosis of Small Intestinal Bacterial Overgrowth

Digestive diseases and sciences, 2021-01, Vol.66 (1), p.160-166

2021

Volltextzugriff (PDF)

High-Definition Colonoscopy Compared With Cuff- and Cap-Assisted Colonoscopy: Results From a Multicenter, Prospective, Randomized Controlled Trial

Clinical gastroenterology and hepatology, 2022-09, Vol.20 (9), p.2023-2031.e6

2022

Volltextzugriff (PDF)

Impact of a ring-fitted cap on insertion time and adenoma detection: a randomized controlled trial

Gastrointestinal endoscopy, 2020-01, Vol.91 (1), p.115-120

2020

Volltextzugriff (PDF)

A comparison of 2 distal attachment mucosal exposure devices: a noninferiority randomized controlled trial

Gastrointestinal endoscopy, 2019-11, Vol.90 (5), p.835-840.e1

2019

Volltextzugriff (PDF)

Correction to: Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose

Digestive diseases and sciences, 2019-07, Vol.64 (7), p.2059-2059

2019

Volltextzugriff (PDF)

Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

The American journal of gastroenterology, 2019-04, Vol.113 (12), p.696-696

2019

Volltextzugriff (PDF)

Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

The American journal of gastroenterology, 2018-09, Vol.113 (9), p.1345

2018

Volltextzugriff (PDF)

S1175 Examination of Dysplasia and Cancer Surveillance Compliance With Guidelines Among Pediatric Onset Inflammatory Bowel Disease at a Tertiary Referral Center

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S899-S900

2023

Volltextzugriff (PDF)

S1174 Healthcare Utilization of Elderly Patients With Inflammatory Bowel Disease on Biologics

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S898-S899

2023

Volltextzugriff (PDF)

S1176 The Impact of Obesity on Healthcare Utilization in Patients with Inflammatory Bowel Disease on Biologics

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S900-S900

2023

Volltextzugriff (PDF)

S0794 Effect of Indiana Legislation on Opioid Prescriptions at a Large Academic Institution for Patients With Inflammatory Bowel Disease

The American journal of gastroenterology, 2020-10, Vol.115 (1), p.S406-S407

2020

Volltextzugriff (PDF)

2103 Fecal bile acids, fecal short-chain fatty acids, and the intestinal microbiota in patients with irritable bowel syndrome (IBS) and control volunteers

Journal of clinical and translational science, 2018-06, Vol.2 (S1), p.12-13

2018

Volltextzugriff (PDF)

Sa1766 EFFECT OF INDIANA OPIOID PRESCRIPTION LEGISLATION ON OPIOID USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-415-S-415

2020

Volltextzugriff (PDF)

Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach

Gut microbes, 2017-05, Vol.8 (3), p.289-302

2017

Volltextzugriff (PDF)

WHICH IS IMPORTANT? GLUTEN FREE DIET OR INFLAMMATORY BOWEL DISEASE MEDICATIONS IN SUBJECTS WITH AN OVERLAP WITH CELIAC DISEASE AND INFLAMMATORY BOWEL DISEASE: OBSERVATIONS FROM A CASE SERIES AT A LARGE ACADEMIC CENTER

Gastroenterology (New York, N.Y. 1943), 2023-04, Vol.164 (4), p.S22-S22

2023

Volltextzugriff (PDF)

Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection

Clinical gastroenterology and hepatology, 2020-09, Vol.18 (10), p.2234-2243.e1

2020

Volltextzugriff (PDF)

Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis

Clinical gastroenterology and hepatology, 2019-02, Vol.17 (3), p.502-509.e1

2019

Volltextzugriff (PDF)

WHICH IS IMPORTANT? GLUTEN FREE DIET OR INFLAMMATORY BOWEL DISEASE MEDICATIONS IN SUBJECTS WITH AN OVERLAP WITH CELIAC DISEASE AND INFLAMMATORY BOWEL DISEASE: OBSERVATIONS FROM A CASE SERIES AT A LARGE ACADEMIC CENTER

Inflammatory bowel diseases, 2023-01, Vol.29 (Supplement_1), p.S16-S17

2023

Volltextzugriff (PDF)

Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

The American journal of gastroenterology, 2018-09, Vol.113 (9), p.1345-1354

2018

Volltextzugriff (PDF)

Mo1264 GLUCAGON ADMINISTRATION IN THE EMERGENCY ROOM FOR ESOPHAGEAL FOOD IMPACTION: DETERMINING ITS EFFICACY AND PREDICTIVE FACTORS OF SUCCESS

Gastrointestinal endoscopy, 2020-06, Vol.91 (6), p.AB406-AB406

2020

Volltextzugriff (PDF)

1 – 25 von 228

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(216)
Mit Volltextzugriff
(185)

Publikationsform

Sprache

Englisch
(227)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Lose Dose

Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis

Impact of withdrawal time on adenoma detection rate: results from a prospective multicenter trial

Diagnosis and Management of Small Intestinal Bacterial Overgrowth

Clinical Presentation of Small Intestinal Bacterial Overgrowth from Aerodigestive Tract Bacteria Versus Colonic-Type Bacteria: A Comparison Study

Delayed Gastric Emptying Is Not Associated with a Microbiological Diagnosis of Small Intestinal Bacterial Overgrowth

High-Definition Colonoscopy Compared With Cuff- and Cap-Assisted Colonoscopy: Results From a Multicenter, Prospective, Randomized Controlled Trial

Impact of a ring-fitted cap on insertion time and adenoma detection: a randomized controlled trial

A comparison of 2 distal attachment mucosal exposure devices: a noninferiority randomized controlled trial

Correction to: Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose

Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

S1175 Examination of Dysplasia and Cancer Surveillance Compliance With Guidelines Among Pediatric Onset Inflammatory Bowel Disease at a Tertiary Referral Center

S1174 Healthcare Utilization of Elderly Patients With Inflammatory Bowel Disease on Biologics

S1176 The Impact of Obesity on Healthcare Utilization in Patients with Inflammatory Bowel Disease on Biologics

S0794 Effect of Indiana Legislation on Opioid Prescriptions at a Large Academic Institution for Patients With Inflammatory Bowel Disease

2103 Fecal bile acids, fecal short-chain fatty acids, and the intestinal microbiota in patients with irritable bowel syndrome (IBS) and control volunteers

Sa1766 EFFECT OF INDIANA OPIOID PRESCRIPTION LEGISLATION ON OPIOID USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach

WHICH IS IMPORTANT? GLUTEN FREE DIET OR INFLAMMATORY BOWEL DISEASE MEDICATIONS IN SUBJECTS WITH AN OVERLAP WITH CELIAC DISEASE AND INFLAMMATORY BOWEL DISEASE: OBSERVATIONS FROM A CASE SERIES AT A LARGE ACADEMIC CENTER

Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection

Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis

WHICH IS IMPORTANT? GLUTEN FREE DIET OR INFLAMMATORY BOWEL DISEASE MEDICATIONS IN SUBJECTS WITH AN OVERLAP WITH CELIAC DISEASE AND INFLAMMATORY BOWEL DISEASE: OBSERVATIONS FROM A CASE SERIES AT A LARGE ACADEMIC CENTER

Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

Mo1264 GLUCAGON ADMINISTRATION IN THE EMERGENCY ROOM FOR ESOPHAGEAL FOOD IMPACTION: DETERMINING ITS EFFICACY AND PREDICTIVE FACTORS OF SUCCESS

Suchergebnisse filtern